Advertisement

Defecatory dysfunction and other clinical variables are predictors of pessary discontinuation

  • Erin G. Dengler
  • Louisa A. Mounsey
  • Francesca Gines
  • Manahil Agha
  • Terri Long
  • Elizabeth J. GellerEmail author
Original Article
  • 54 Downloads

Abstract

Introduction and hypothesis

Pessaries provide first-line therapy for women with pelvic organ prolapse (POP) and stress urinary incontinence (SUI). The primary hypothesis was that defecatory dysfunction was associated with pessary discontinuation.

Methods

This was a retrospective cohort study of all women undergoing first pessary placement at one academic center from April 2014 to January 2017. Defecatory dysfunction was defined as the presence of constipation, rectal straining, rectal splinting, and/or incomplete defecation. Pessary discontinuation was defined as <1 year of pessary use and not using one at the most recent visit. Descriptive statistics; Person’s chi-square, Fisher’s exact, and Student’s t test, and multivariate logistic regression analysis were used where appropriate.

Results

Charts of 1092 women were reviewed and 1071 were included. Mean age was 62 ± 15 years, mean body mass index (BMI) 28 ± 6 kg/m2, and mean parity 2 ± 1; 68% were Caucasian, 73% were menopausal, and 41% were sexually active. Reason for pessary use included POP (46%), SUI (24%), or both (30%). Overall pessary discontinuation rate was 77%; overall rate of defecatory dysfunction was 45%. In a logistic regression model, defecatory dysfunction in the form of incomplete defecation remained significantly associated with pessary discontinuation [odds ratio (OR) 3.29, 95% confidence interval (CI) 1.43–7.52]. Absence of bulge symptoms (OR 2.18, 95% CI 1.22–3.90), and younger age (OR 1.02, 95% CI 1.02–1.05) also remained significantly associated with pessary discontinuation.

Conclusions

Pessary discontinuation was common, and defecatory dysfunction in the form of incomplete defecation had the strongest association with discontinuation. Understanding predictive factors of pessary discontinuation may help guide clinicians and patients when choosing treatment options for pelvic floor dysfunction.

Keywords

Defecatory dysfunction Pessary Pessary discontinuation Predictors 

Notes

Compliance with ethical standards

Conflicts of interest

None.

References

  1. 1.
    Pott-Grinstein E, Newcomer JR. Gynecologists’ patterns of prescribing pessaries. J Reprod Med. 2001;46(3):205–8.Google Scholar
  2. 2.
    Cundiff GW, et al. A survey of pessary use by members of the American urogynecologic society. Obstet Gynecol. 2000;95(6 Pt 1):931–5.Google Scholar
  3. 3.
    Robert M, Schulz JA, Harvey MA. Technical update on pessary use. J Obstet Gynaecol Can. 2013;35(7):664–74.CrossRefGoogle Scholar
  4. 4.
    Meriwether KV, et al. Sexual function and pessary management among women using a pessary for pelvic floor disorders. J Sex Med. 2015;12(12):2339–49.CrossRefGoogle Scholar
  5. 5.
    Manchana T. Ring pessary for all pelvic organ prolapse. Arch Gynecol Obstet. 2011;284(2):391–5.CrossRefGoogle Scholar
  6. 6.
    Cheung RY, et al. Vaginal pessary in women with symptomatic pelvic organ prolapse: a randomized controlled trial. Obstet Gynecol. 2016;128(1):73–80.CrossRefGoogle Scholar
  7. 7.
    Bai SW, et al. Survey of the characteristics and satisfaction degree of the patients using a pessary. Int Urogynecol J Pelvic Floor Dysfunct. 2005;16(3):182–6 discussion 186.CrossRefGoogle Scholar
  8. 8.
    Gorti M, Hudelist G, Simons A. Evaluation of vaginal pessary management: a UK-based survey. J Obstet Gynaecol. 2009;29(2):129–31.CrossRefGoogle Scholar
  9. 9.
    Lone F, et al. A 5-year prospective study of vaginal pessary use for pelvic organ prolapse. Int J Gynaecol Obstet. 2011;114(1):56–9.CrossRefGoogle Scholar
  10. 10.
    Sarma S, Ying T, Moore KH. Long-term vaginal ring pessary use: discontinuation rates and adverse events. Bjog. 2009;116(13):1715–21.CrossRefGoogle Scholar
  11. 11.
    Barber MD, Walters MD, Bump RC. Short forms of two condition-specific quality-of-life questionnaires for women with pelvic floor disorders (PFDI-20 and PFIQ-7). Am J Obstet Gynecol. 2005;193(1):103–13.CrossRefGoogle Scholar
  12. 12.
    Bump RC, et al. The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRefGoogle Scholar
  13. 13.
    Sullivan SA, et al. Patient characteristics associated with treatment choice for pelvic organ prolapse and urinary incontinence. Int Urogynecol J. 2016;27(5):811–6.CrossRefGoogle Scholar
  14. 14.
    Clemons JL, et al. Patient characteristics that are associated with continued pessary use versus surgery after 1 year. Am J Obstet Gynecol. 2004;191(1):159–64.CrossRefGoogle Scholar
  15. 15.
    Geoffrion R, et al. Clinical characteristics associated with unsuccessful pessary fitting outcomes. Female Pelvic Med Reconstr Surg. 2013;19(6):339–45.CrossRefGoogle Scholar
  16. 16.
    Markle D, et al. Patient characteristics associated with a successful pessary fitting. Female Pelvic Med Reconstr Surg. 2011;17(5):249–52.Google Scholar
  17. 17.
    Brincat C, et al. Sexual activity predicts continued pessary use. Am J Obstet Gynecol. 2004;191(1):198–200.CrossRefGoogle Scholar

Copyright information

© The International Urogynecological Association 2018

Authors and Affiliations

  1. 1.School of MedicineUniversity of North Carolina at Chapel HillChapel HillUSA
  2. 2.University of North Carolina at Chapel HillChapel HillUSA
  3. 3.Division of Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, School of MedicineUniversity of North Carolina at Chapel HillChapel HillUSA

Personalised recommendations